Researching: Eli Lilly
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "Eli Lilly"...
RxInsider Coverage (10)
The Week
TRex Bio prices $117M IPO to support immune drug work
Oct 9
The Week
Lilly-Foghorn split, Teva-Samsung Bioepis expansion, and Varda’s $251 million raise
Oct 3
The Week
3 takeaways from a European obesity scientific meeting
Oct 1
The Week
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer's data
Sep 25
The Week
Novo talks up drug launches in effort to win back investors
Sep 23
The Week
The Oral GLP-1 Tracker: Holiday takes toll on prescriptions
Sep 21
The Week
Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo
Sep 19
The Week
China deal flow holds up as biotech stocks wobble and Lilly keeps buying
Sep 5
The Week
Medicare’s $50 GLP-1 bridge model gives Lilly and Novo a demand signal
Sep 4
The Week
Lilly’s Merida deal opens an autoimmune platform bet
Sep 1
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.